Management of Raynaud's phenomenon in pregnancy commonly includes which therapy?

• A. Peripheral vasodilators
• B. Beta-blockers
• C. ACE inhibitors
• D. Corticosteroids

Answer: (A)

Raynaud's phenomenon in pregnancy is best managed by improving blood flow to the extremities through peripheral vasodilation. When small digital arteries spasm in response to cold or stress, using peripheral vasodilators helps relax those vessels, increasing perfusion and reducing attack frequency and severity. Calcium channel blockers are a common example of this approach and are used because they effectively lessen vasospasm during pregnancy with careful monitoring. Other options are not preferred: ACE inhibitors are avoided in pregnancy due to fetal risks, beta-blockers can have neonatal and fetal effects, and corticosteroids do not address the vasospastic mechanism and are not indicated for this condition.